IART
Integra LifeSciences Holdings
15.50$
-3.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18.9% | +23.2% | -1.6% | +74.3% | +15.9% | -11.9% | +53.3% | -15.4% | -47.1% | -7.6% | -61.1% | |
| – | -3.7% | +23.4% | +22.4% | +24.5% | -1.1% | +6.0% | +3.3% | -1.3% | +4.4% | +14.1% | +7.8% | |
| – | +2.3% | +12.0% | +24.5% | -3.6% | +2.3% | -7.8% | +84.8% | -23.4% | -27.3% | +21.0% | -23.8% | |
| – | +230.7% | -72.8% | -422.1% | – | -45.8% | -499.5% | – | -98.3% | – | – | – | |
| – | – | – | – | – | -930.5% | – | – | -317.0% | – | – | – | |
| – | -21.2% | +41.6% | -8.1% | +78.7% | +73.1% | -52.5% | -24.7% | -2.1% | +42.0% | +56.2% | -8.4% | |
| – | +2.4% | -88.5% | +2,765.5% | -95.9% | +227.3% | -58.2% | +137.2% | -63.7% | +60.8% | +315.0% | -72.3% | |
| – | – | – | – | – | – | +10,168.0% | -95.5% | +170.1% | +1,606.2% | – | – | |
| – | +1,392.0% | -102.1% | +46.8% | +9.8% | -16.7% | +1,435.2% | -95.2% | +2,503.6% | +120.0% | -80.9% | -99.6% | |
| – | -67.0% | -127.8% | – | -142.2% | -98.1% | – | -135.7% | +7.5% | – | +449.3% | -83.0% | |
| – | +6.5% | -105.8% | – | -115.5% | -95.2% | – | -180.8% | +156.5% | -8.7% | – | -88.1% | |
| – | – | – | +35.2% | -149.5% | – | +351.5% | -84.0% | -231.2% | – | – | – | |
| – | +64.8% | +13.1% | +2.8% | +71.7% | -20.5% | +44.4% | +88.9% | -17.8% | -66.4% | -65.8% | -281.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.